These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 4157277)

  • 1. A possible mechanism for the anti-depressant activity of thyrotropin releasing hormone.
    Horst WD; Spirt N
    Life Sci; 1974 Sep; 15(6):1073-82. PubMed ID: 4157277
    [No Abstract]   [Full Text] [Related]  

  • 2. Thyrotropin-releasing hormone--increased catabolism of catecholamines in brains of thyroidectomized rats.
    Marek K; Haubrich DR
    Biochem Pharmacol; 1977 Oct; 26(19):1817-8. PubMed ID: 410420
    [No Abstract]   [Full Text] [Related]  

  • 3. Changes in brain catecholamines and spontaneous locomotor activity in response to thyrotropin releasing hormone.
    Agarwal RA; Rastogi RB; Singhal RL
    Res Commun Chem Pathol Pharmacol; 1976 Dec; 15(4):743-52. PubMed ID: 12549
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enhancement of cerebral noradrenaline turnover by thyrotropin-releasing hormone: evidence by fluorescence histochemistry.
    Constantinidis J; Geissbühler F; Gaillard JM; Hovaguimian T; Tissot R
    Experientia; 1974 Oct; 30(10):1182-3. PubMed ID: 4215671
    [No Abstract]   [Full Text] [Related]  

  • 5. Thyrotropin releasing hormone: neurochemical evidence for the potentiation of imipramine effects on the metabolism and uptake of brain catecholamines.
    Rastogi RB; Singhal RL; Lapierre YD
    Psychopharmacology (Berl); 1980; 72(1):85-91. PubMed ID: 6110219
    [No Abstract]   [Full Text] [Related]  

  • 6. Cocaine- and amphetamine-regulated transcript peptide-(55-102) and thyrotropin releasing hormone inhibit hypothalamic dopamine release.
    Brunetti L; Orlando G; Michelotto B; Recinella L; Vacca M
    Eur J Pharmacol; 2000 Dec; 409(2):103-7. PubMed ID: 11104823
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Studies on the interaction between catecholamines and tyrosine aminotransferase in brain.
    Zigmond MJ; Wilson SP
    Biochem Pharmacol; 1973 Sep; 22(17):2151-63. PubMed ID: 4147420
    [No Abstract]   [Full Text] [Related]  

  • 8. Biochemical characteristics of a potential antidepressant, 2-(7-indenyloxymethyl)morpholine hydrochloride (YM-08054-1).
    Harada M; Maeno H
    Biochem Pharmacol; 1979 Sep; 28(17):2645-51. PubMed ID: 518676
    [No Abstract]   [Full Text] [Related]  

  • 9. TRH on rat conditioned avoidance behavior: interaction with brain catecholamines.
    Mora S; Nasello AG; Fieschi L
    Pharmacol Biochem Behav; 1980 Jul; 13(1):137-9. PubMed ID: 6773073
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Investigations on the interaction of thyrotropin-releasing hormone (TRH) and MK-771 with central noradrenergic mechanisms.
    Lotti VJ; Yarbrough GG; Clineschmidt BV
    Psychopharmacology (Berl); 1980; 70(2):145-8. PubMed ID: 6776573
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enhancement of cerebral noradrenaline turnover by thyrotropin-releasing hormone.
    Keller HH; Bartholini G; Pletscher A
    Nature; 1974 Apr; 248(448):528-9. PubMed ID: 4207412
    [No Abstract]   [Full Text] [Related]  

  • 12. Modulation of catecholamine metabolism in synaptosomes by a neuroregulatory factor from mammalian brain.
    Pastuszko A; Yee DK; Wilson DF
    Neurosci Lett; 1989 Mar; 98(1):111-7. PubMed ID: 2710394
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Catecholaminergic control of thyrotropin secretion.
    Montoya E; Wilber JF; Lorincz M
    J Lab Clin Med; 1979 May; 93(5):887-94. PubMed ID: 219126
    [No Abstract]   [Full Text] [Related]  

  • 14. Catecholamines in brain ischemia--effects of alpha-methyl-p-tyrosine and pargyline.
    Mrsulja BB; Mrsulja BJ; Spatz M; Klatzo I
    Brain Res; 1976 Mar; 104(2):373-8. PubMed ID: 1260436
    [No Abstract]   [Full Text] [Related]  

  • 15. Proceedings: Thyrotropin-releasing hormone: activation of cerebral noradrenaline turnover.
    Keller HH; Bartholini G
    Naunyn Schmiedebergs Arch Pharmacol; 1974; 282(Suppl):suppl 282:R46. PubMed ID: 4276583
    [No Abstract]   [Full Text] [Related]  

  • 16. The effects of thyrotropin-releasing hormone on the behaviour of rats pretreated with alpha-methyltyrosine.
    Kulig BM
    Neuropharmacology; 1975 Jul; 14(7):489-92. PubMed ID: 807866
    [No Abstract]   [Full Text] [Related]  

  • 17. [Releasing hormone on the lateral hypothalamus self-stimulation behavior of rats (author's transl)].
    Kojima H; Inanaga K; Noda Y; Kawaguchi E; Kajiwara U
    No To Shinkei; 1977 Nov; 29(11):1207-13. PubMed ID: 412506
    [No Abstract]   [Full Text] [Related]  

  • 18. Basis of phencyclidine's ability to decrease the synaptosomal accumulation of 3H-catecholamines.
    Ary TE; Komiskey HL
    Eur J Pharmacol; 1980 Feb; 61(4):401-5. PubMed ID: 7371716
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A comparison of the inhibitory effects of aromatic substituted benzhydryl ethers on the uptake of catecholamines and serotonin into synaptosomal preparations of the rat brain.
    Van der Zee P; Hespe W
    Neuropharmacology; 1978 Jul; 17(7):483-90. PubMed ID: 692814
    [No Abstract]   [Full Text] [Related]  

  • 20. Effects of thyrotropin- and corticotropin-releasing hormone on blood pressure and plasma catecholamines in the anesthetized rat.
    Schulz C; Christodulopulu E; Bock A; Kretz M; Beyer J; Lehnert H
    Neuropsychobiology; 1994; 30(4):178-84. PubMed ID: 7862266
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.